12- Week Open Label Treatment of Refractory Bipolar Depression

Completed · Phase 4

Conditions studied: Bipolar Disorder

In brief

1. Determine the change in symptomatology and function in refractory bipolar depression, when treated with combination of DEP+AZP for a period of 12 weeks 2. Determine the tolerability and safety of AZP added to DEP in the treatment of refractory bipolar depression

Key facts

Study ID
NCT00223496
Run by
The University of Texas Health Science Center at San Antonio
People needed
32
Starts
2004-09-01
Expected to finish
2009-09-01
Last updated by the study team
2017-05-16

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.